Article
Alcon submits PMA application
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits
3 Things You Should Know About Interventional Glaucoma Comanagement
Annexon completes enrollment in phase 3 ARCHER II trial of vonaprument for geographic atrophy
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Scuba divers and surfers face dual light exposure that may accelerate AMD
Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence